Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones.
D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D004156:Catechol Oxidase / Q000032:analysis*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D000242:Cyclic AMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D008543:Melanins / Q000096:biosynthesis*; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology*; D008545:Melanoma / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D009374:Neoplasms, Experimental; D010641:Phenotype; D014176:Protein Biosynthesis / Q000187:drug effects; D012334:RNA, Neoplasm / Q000096:biosynthesis; D014158:Transcription, Genetic / Q000187:drug effects; D014316:Tritium
D002087:Butyrates; D004273:DNA, Neoplasm; D008543:Melanins; D012334:RNA, Neoplasm; D014316:Tritium; D003609:Dactinomycin; D009074:Melanocyte-Stimulating Hormones; D003513:Cycloheximide; D000242:Cyclic AMP; D004156:Catechol Oxidase